Molecular genetic diagnosis of Bernard-Soulier syndrome in Iranian patients: reporting three novel mutations
Genetic testing identifies new disease mutations in rare bleeding disorder patients from Iran, improving diagnosis and genetic counseling in underserved regions.
Sanger sequencing in 8 Iranian Bernard-Soulier syndrome patients reveals 6 disease-causing mutations including 3 previously unreported variants in GP9 and GP1BA genes. This adds to the mutational spectrum of this rare platelet disorder with diagnostic utility for genetic counseling in Middle Eastern populations.
What the study was
- Study design
- Case series with molecular characterization
- Population
- Iranian patients with Bernard-Soulier syndrome
- Sample size
- 8
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Transfusion and Apheresis Science
Why it surfaced
Reports novel mutations in a rare congenital platelet disorder; primarily of diagnostic/genetic counseling value. Small series (n=8) limits clinical impact but adds to mutation database for an underdiagnosed rare disease.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.